Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy

HIF-1α affects sensitivity of murine squamous cell carcinoma to boron neutron capture therapy with BPA

(2021) Yu Sanada et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

TIMER2.0 for analysis of tumor-infiltrating immune cells

(2020) Taiwen Li et al.   NUCLEIC ACIDS RESEARCH

Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)

(2020) Junichi Hiratsuka et al.   JOURNAL OF RADIATION RESEARCH

Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial

(2020) Katsumi Hirose et al.   RADIOTHERAPY AND ONCOLOGY

Disruption of Hif-1α enhances cytotoxic effects of metformin in murine squamous cell carcinoma

(2017) Yu Sanada et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Development and Elucidation of a Novel Fluorescent Boron-Sensor for the Analysis of Boronic Acid-Containing Compounds

(2017) Yoshihide Hattori et al.   SENSORS

Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes

(2016) Van Trung Chu et al.   BMC BIOTECHNOLOGY

Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [18F]-L-FBPA positron emission tomography in boron neutron capture therapy

(2016) Tsubasa Watanabe et al.   BMC CANCER

L-phenylalanine preloading reduces the 10B(n, α)7Li dose to the normal brain by inhibiting the uptake of boronophenylalanine in boron neutron capture therapy for brain tumours

(2016) Tsubasa Watanabe et al.   CANCER LETTERS

Visualization of Boronic Acid Containing Pharmaceuticals in Live Tumor Cells Using a Fluorescent Boronic Acid Sensor

(2016) Yoshihide Hattori et al.   ACS Sensors

Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2

(2015) Printip Wongthai et al.   CANCER SCIENCE

Detection of boronic acid derivatives in cells using a fluorescent sensor

(2015) Yoshihide Hattori et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009

(2014) Keisha A. Houston et al.   LUNG CANCER

FBPA PET in boron neutron capture therapy for cancer: prediction of 10B concentration in the tumor and normal tissue in a rat xenograft model

(2014) Kohei Hanaoka et al.   EJNMMI Research

Predominant contribution of L-type amino acid transporter to 4-borono-2-18F-fluoro-phenylalanine uptake in human glioblastoma cells

(2013) Mitsuyoshi Yoshimoto et al.   NUCLEAR MEDICINE AND BIOLOGY

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

(2012) Rolf F Barth et al.   Radiation Oncology

BPA uptake does not correlate with LAT1 and Ki67 expressions in tumor samples (results of EORTC trial 11001)

(2011) Andrea Wittig et al.   APPLIED RADIATION AND ISOTOPES

L-Amino Acid Transporter-1 and Boronophenylalanine-Based Boron Neutron Capture Therapy of Human Brain Tumors

(2009) A. Detta et al.   CANCER RESEARCH

Boron Neutron Capture Therapy for Newly Diagnosed Glioblastoma

(2009) Shinji KAWABATA et al.   JOURNAL OF RADIATION RESEARCH